Newsroom | 2915 results

CORVALLIS, Ore. & MEDFORD, Mass.--(BUSINESS WIRE)--BioTesserae Inc. (BTC), a biotechnology company focused on innovative veterinary therapeutics, in collaboration with Sunflower Therapeutics PBC, a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, today announced that BTC-001 was well tolerated in healthy dogs following a single ascending dose study. BTC-001 is a single domain antibody (SdA) that recognizes the immune checkpoint in...

AUSTIN--(BUSINESS WIRE)--Pet Honesty®, the science-driven pet wellness brand, launches in Walmart nationwide, bringing total distribution to nearly 13,000 stores in the US....

NEW YORK--(BUSINESS WIRE)--Bond Vet, a leading provider of modern, accessible veterinary care, today announced the official launch of its new Bond Vet Membership program, designed to make high-quality care more accessible while strengthening long-term relationships between pet parents and care teams. The membership program introduces a simple, client-friendly model that prioritizes preventative care and ongoing engagement. Key benefits include a fully covered first exam, 20% off all future exam...

SAN FRANCISCO--(BUSINESS WIRE)--A new report released today from the top veterinary telemedicine provider, Dutch, reveals a growing divide at the intersection of pet ownership, rising costs, and limited access to care. According to the Pet Care Gap Report, an estimated 75 million pet parents have skipped or declined veterinary care due to cost or access barriers, highlighting opportunities for virtual care to improve access and outcomes for pets nationwide. Olympic gold medalist and devoted pet...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 first quarter financial results for Tuesday, May 5, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q1 2026 Earnings Snapshot through a link on the IDEXX website,...

PLANTATION, Fla.--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) (“Chewy”), today announced it has entered into a definitive agreement to acquire Modern Animal, Inc. (“Modern Animal”), a technology-forward veterinary platform with 29 owned clinics, 24/7 virtual care, and a high-retention membership model. This acquisition represents an important strategic step in Chewy’s evolution into a fully integrated pet healthcare ecosystem, combining care, commerce and services across the pet lifecycle. Modern...

MIAMI--(BUSINESS WIRE)--Petwealth raises $1.7M, advancing at-home pet PCR diagnostics, AI health insights, and key partnerships in vet telehealth and pet service software....

SYDNEY, Australia--(BUSINESS WIRE)--Parnell today announced the acquisition of Noble Pharma LLC, a U.S.-based pharmaceutical manufacturer, according to the Securities Purchase Agreement dated November 26, 2025. With this strategic acquisition, Parnell strengthens its U.S. operations and further advances its long-term commitment to delivering high‑quality products, reliable supply, and an enhanced level of support to its customers and distribution partners. Noble Pharma significantly enhances Pa...

紐約--(BUSINESS WIRE)--(美國商業資訊)-- 香料、香水、食品配料、健康和生物科學領域的全球領導者IFF (NYSE: IFF)推出專為犬類消化健康開發的新型益生菌產品PureStrong™。 如今，許多人將寵物狗視為家庭成員。這一觀念改變推動美國寵物補充品市場迎來快速發展，該市場規模已達32億美元。近半數美國寵物主人已為自家狗狗購買或正考量購買益生菌，而PureStrong™樹立了全新產業標準：秉持「寵物優先」構想，根據犬類生理特徵打造專屬科學配方。 IFF健康科學資深副總裁Allyson Fish表示：「PureStrong™的菌株直接擷取自健康犬類的微生物群，研發設計貼合狗狗的實際生活狀態，適配它們的飲食、出行、衰老過程以及因應環境變化的需求。這正是IFF引領寵物健康領域的核心思路：以科學為驅動進行創新，讓產品在實際場景中發揮實效。」 這款獨特的犬用益生菌隸屬於IFF旗下HOWARU® Pet寵物益生菌系列，該系列包含專為犬貓研發的益生菌菌株，並由微生物群科學研究、優質生產製程和臨床評估提供支撐。IFF在益生菌與生物科學領域擁有數十年領先經驗，正協助寵物健康品牌...

纽约--(BUSINESS WIRE)--(美国商业资讯)-- 香料、香水、食品配料、健康和生物科学领域的全球领导者IFF (NYSE: IFF)推出专为犬类消化健康开发的新型益生菌产品PureStrong™。 如今，许多人将宠物狗视作家庭成员。这一观念转变推动美国宠物补充剂市场迎来快速发展，该市场规模已达32亿美元。近半数美国宠物主人已为自家狗狗购买或正考虑购买益生菌，而PureStrong™树立了全新行业标准：秉持“宠物优先”理念，基于犬类生理特征打造专属科学配方。 IFF健康科学高级副总裁Allyson Fish表示：“PureStrong™的菌株直接提取自健康犬类的微生物群，研发设计贴合狗狗的实际生活状态，适配它们的饮食、出行、衰老过程以及应对环境变化的需求。这正是IFF引领宠物健康领域的核心思路：以科学为驱动进行创新，让产品在实际场景中发挥实效。” 这款独特的犬用益生菌隶属于IFF旗下HOWARU® Pet宠物益生菌系列，该系列包含专为犬猫研发的益生菌菌株，依托微生物群科学研究、高品质生产工艺和临床评估打造。IFF在益生菌与生物科学领域拥有数十年领先经验，正助力宠物健康品牌摆...